Home > Insider Trading > Filing (0001209191-15-009192)

Filing Details

Accession Number:: 0001209191-15-009192
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2015-02-03 20:51:08
Reporting Period:: 2015-01-30

Filing Date:: 2015-02-03
Accepted Time:: 2015-02-03 20:51:08
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
69499	Mylan Inc.	MYL	Pharmaceutical Preparations (2834)	251211621

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1197539	L Randall Vanderveen	1000 Mylan Blvd Canonsburg PA 15317		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2015-01-30	10,000	$20.86	45,787	No	4	M	Direct
Common Stock	Acquisiton	2015-01-30	10,000	$22.00	55,787	No	4	M	Direct
Common Stock	Acquisiton	2015-01-30	9,088	$15.80	64,875	No	4	M	Direct
Common Stock	Disposition	2015-01-30	29,088	$53.73	35,787	No	4	S	Direct
Common Stock	Acquisiton	2015-02-02	912	$15.80	36,699	No	4	M	Direct
Common Stock	Acquisiton	2015-02-02	19,994	$12.96	56,693	No	4	M	Direct
Common Stock	Acquisiton	2015-02-02	14,286	$13.43	70,979	No	4	M	Direct
Common Stock	Acquisiton	2015-02-02	10,271	$20.52	81,250	No	4	M	Direct
Common Stock	Disposition	2015-02-02	45,463	$52.87	35,787	No	4	S	Direct
Common Stock	Acquisiton	2015-02-03	1,355	$20.52	37,142	No	4	M	Direct
Common Stock	Acquisiton	2015-02-03	10,864	$23.90	48,006	No	4	M	Direct
Common Stock	Acquisiton	2015-02-03	13,158	$21.00	61,164	No	4	M	Direct
Common Stock	Acquisiton	2015-02-03	6,623	$31.63	67,787	No	4	M	Direct
Common Stock	Disposition	2015-02-03	32,000	$53.01	35,787	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Non-Employee Director Stock Option - Right to Buy	Disposition	2015-01-30	10,000	$0.00	10,000	$20.86
Common Stock	Non-Employee Director Stock Option - Right to Buy	Disposition	2015-01-30	10,000	$0.00	10,000	$22.00
Common Stock	Non-Employee Director Stock Option - Right to Buy	Disposition	2015-01-30	9,088	$0.00	9,088	$15.80
Common Stock	Non-Employee Director Stock Option - Right to Buy	Disposition	2015-02-02	912	$0.00	912	$15.80
Common Stock	Non-Employee Director Stock Option - Right to Buy	Disposition	2015-02-02	19,994	$0.00	19,994	$12.96
Common Stock	Non-Employee Director Stock Option - Right to Buy	Disposition	2015-02-02	14,286	$0.00	14,286	$13.43
Common Stock	Non-Employee Director Stock Option - Right to Buy	Disposition	2015-02-02	10,271	$0.00	10,271	$20.52
Common Stock	Non-Employee Director Stock Option - Right to Buy	Disposition	2015-02-03	1,355	$0.00	1,355	$20.52
Common Stock	Non-Employee Director Stock Option - Right to Buy	Disposition	2015-02-03	10,864	$0.00	10,864	$23.90
Common Stock	Non-Employee Director Stock Option - Right to Buy	Disposition	2015-02-03	13,158	$0.00	13,158	$21.00
Common Stock	Non-Employee Director Stock Option - Right to Buy	Disposition	2015-02-03	6,623	$0.00	6,623	$31.63

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2015-11-28	No	4	M	Direct
0	2016-07-28	No	4	M	Direct
912	2017-07-27	No	4	M	Direct
0	2017-07-27	No	4	M	Direct
0	2018-04-25	No	4	M	Direct
0	2019-05-07	No	4	M	Direct
1,355	2020-05-14	No	4	M	Direct
0	2020-05-14	No	4	M	Direct
0	2021-05-06	No	4	M	Direct
0	2022-05-04	No	4	M	Direct
0	2023-05-28	No	4	M	Direct

Footnotes

Represents acquisition of Mylan common stock upon exercise of stock options granted on November 28, 2005.
Represents acquisition of Mylan common stock upon exercise of stock options granted on July 28, 2006.
Represents acquisition of Mylan common stock upon exercise of stock options granted on July 27, 2007.
Represents the weighted average price of shares sold by the broker on behalf of certain non-employee directors and executive officers of Mylan on January 30, 2015. The broker sold, in the aggregate on behalf of such non-employee directors and executive officers, 403,595 shares in transactions ranging from $53.01 to $54.00 with a weighted average price of $53.5684 as well as 205,341 shares in transactions ranging from $54.005 to $54.25 with a weighted average price of $54.0425. The proceeds of all such sales were allocated to the applicable non-employee directors and executive officers on a pro rata basis based on the number of shares sold by such person.
Represents acquisition of Mylan common stock upon exercise of stock options granted on April 25, 2008.
Represents acquisition of Mylan common stock upon exercise of stock options granted on May 7, 2009.
Represents acquisition of Mylan common stock upon exercise of stock options granted on May 14, 2010.
Represents the weighted average price of shares sold by the broker on behalf of certain non-employee directors and executive officers of Mylan on February 2, 2015. The broker sold, in the aggregate on behalf of such non-employee directors and executive officers, 937,763 shares in transactions ranging from $52.23 to $53.22 with a weighted average price of $52.8646 as well as 13,957 shares in transactions ranging from $53.23 to $53.745 with a weighted average price of $53.5027. The proceeds of all such sales were allocated to the applicable non-employee directors and executive officers on a pro rata basis based on the number of shares sold by such person.
Represents acquisition of Mylan common stock upon exercise of stock options granted on May 6, 2011.
Represents acquisition of Mylan common stock upon exercise of stock options granted on May 4, 2012.
Represents acquisition of Mylan common stock upon exercise of stock options granted on May 28, 2013.
Represents the weighted average price of shares sold by the broker on behalf of certain non-employee directors and executive officers of Mylan on February 3, 2015. The broker sold, in the aggregate on behalf of such non-employee directors and executive officers, 520,475 shares in transactions ranging from $52.50 to $53.25 with a weighted average price of $52.8739 as well as 149,400 shares at $53.50 and 1 share at $54.50. The proceeds of all such sales were allocated to the applicable non-employee directors and executive officers on a pro rata basis based on the number of shares sold by such person.
This option exercise and the related sale of the underlying common stock were executed pursuant to a 10b5-1 trading plan dated November 9, 2014.
These options vested in full on November 28, 2005.
These options vested in full on July 28, 2006.
These options vested in full on July 27, 2007.
These options vested in full on April 25, 2009.
These options vested in full on May 7, 2010.
These options vested in full on May 14, 2011.
These options vested in full on May 6, 2012.
These options vested in full on May 4, 2013.
These options vested in full on May 28, 2014.